Regulation of p53: a collaboration between Mdm2 and MdmX

Pei, Dongsheng, Zhang, Yanping, Zheng, Junnian·2012·Oncotarget
DOI 10.18632/oncotarget.443

Cited by (140)

Items 101–140 of 140

  1. LQFM030 reduced Ehrlich ascites tumor cell proliferation and VEGF levels
    Mariana Flávia da Mota, Flávio Silva de Carvalho, Renato Ivan de Ávila, Paulo Henrique Marcelino de Ávila, Alane Pereira Cortez, Ricardo Menegatti, J.R. Sabino, Thaís Rosa Marques dos Santos, Sandro Antônio Gomes, Luíz Carlos da Cunha et al. · 2017 · Life Sciences
  2. Nanoprobe NAPPA Arrays for the Nanoconductimetric Analysis of Ultra-Low-Volume Protein Samples Using Piezoelectric Liquid Dispensing Technology
    Eugenia Pechkova, Peter J. Wiktor, Nicola Luigi Bragazzi, Festa Fernanda, Claudio Ando Nicolini · 2015 · NanoWorld Journal
  3. Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles
    María González-Tablas, Inês Crespo, Ana Luísa Vital, Álvaro Otero, Ana Belén Nieto Librero, Pablo Sousa, María Carmen Patino-Alonso, Luis Antonio Corchete, Hermínio Tão, Olinda Rebelo et al. · 2018 · Oncotarget
  4. Extra-Ribosome Functions of Ribosomal Proteins
    Derek A. Franklin, Y. Zhang · 2015 · Elsevier eBooks
  5. Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c‑Myc and p53 substrates in patients with dysplastic nevi or melanoma
    Julija Mozūraitienė, Živilė Gudlevičienė, Ieva Vincerževskienė, Aida Laurinavičienė, Justinas Pamedys · 2020 · Oncology Letters
  6. Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors
    Yasuko Kitagishi, Satoru Matsuda, Akari Minami, Yuna Ono, Atsuko Nakanishi, Yasunori Ogura · 2014 · Cancer Studies and Molecular Medicine - Open Journal
  7. Decoding the Central Dogma: Quantitative Insights into Transcription and Translation Dynamics in the p53-Mediated DNA Damage Response
    Joshua François, Ashwini Jambhekar, Galit Lahav · 2025 · Journal of Molecular Biology
  8. DHRS2 is a potential marker of breast cancer metastasis
    Burcu Salman Yaylaz, Sema Sırma Ekmekçi, Suzan Çınar, Günnur Deniz, Neslihan Abacı · 2021 · Gene Reports
  9. The Role of Non-Coding RNAs in the Regulation of Oncogenic Pathways in Breast and Gynaecological Cancers
    Ammar Ansari, Aleksandra Szczesnowska, Natalia Ferreira Haddad, Ahmed Elbediwy, Nadine Wehida · 2025 · Non-Coding RNA
  10. VEGF and p53 Biomarkers in Pediatric Patients With Langerhans Cell Histiocytosis
    Mitra Mehrazma, Fatemeh Mahjoob, Khadijeh Arjmandi Rafsanjani, Daniel Jafari, Sahar J. Farahani, Arash Lahouti Harahdashti · 2013 · Journal of Pediatric Hematology/Oncology
  11. The evolution of Nutlins as p53-MDM2 inhibitors
    Daniil R. Bazanov, Natalia A. Lozinskaya · 2025 · Medicinal Chemistry Research
  12. Cardiac Cytoarchitecture: How to Maintain a Working Heart—Waste Disposal and Recycling in Cardiomyocytes
    Jordan Blondelle, Stephan Lange · 2015 · Springer eBooks
  13. Investigation of MDM2 Oncogene Copy Number Alterations in Cases of Chronic Lymphocytic Leukemia
    Şule Darbaş, Çiğdem Aydın, Ozan Salim, Sibel Berke Karaüzüm · 2019 · Turkish Journal of Hematology
  14. Molecular and Cellular Basis of Chemoresistance in Ovarian Cancer
    Meshach Asare-Werehene, Dar‐Bin Shieh, Yong Sang Song, Benjamin K. Tsang · 2018 · Elsevier eBooks
  15. Stapled peptidomimetic therapeutics
    Srinivasaraghavan Kannan, Dilraj Lama, Yaw Sing Tan, Jianguo Li, Chandra Shekhar Verma · 2022 · Elsevier eBooks
  16. The Role of Pirh2 E3 Ligases in Ubiquitination and p73 Regulation
    Abou Zeinab, Rami M · 2015 · ERA: Education and Research Archive (University of Alberta)
  17. Tumour suppressor proteins in proliferating and differentiating cells
    Umesh Madan Bodalina · 2014 · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
  18. Expression levels of MDM2 and MDMX proteins and their associated effects on P53 in human liposarcomas
    Nader Touqan · 2014 · UPT. Syiah Kuala University Library (Syiah Kuala University)
  19. Retraction: ‘p53‐induced Rap2B positively regulates migration in cells exposed to glucose deprivation’ by D.‐S. Pei, J.‐H. Di, W.‐Q. Du and J.‐N. Zheng
    2015 · Molecular Carcinogenesis · Retracted
  20. The Role and Regulation of the Phosphatase PPM1D in Chemoresistant Gynecological Cancers
    Ahmed Ali · 2014 · uO Research (University of Ottawa)
  21. Towards the Investigation of the Effects of Nitration on the Activity of the Human p53 Tumour Suppressor Protein. Nitration of the p53 Tumour Suppressor Protein
    Roslina Husaini · 2014 · Bradford Scholars (University of Bradford)
  22. Generation of reporter cell lines by genome editing to probe p53 activity
    Nazife Tolay · 2018 · Sabanci University
  23. Macrocyclization of an all-D linear peptide improves target affinity and imparts cellular activity: A novel stapled alpha-helical peptide modality
    Shimin Jiang, Christopher John Brown · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Characterization of synthetic lethality between Mdm2 overexpression and genotoxic agents and identification of a novel function of the Mdmx oncogene in DNA repair
    Alexia M. Carrillo · 2014
  25. Oncogenic alterations in the p53 pathway abolish oscillatory competence
    Lingyun Xiong, Alan Garfinkel · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  26. MDM4
    Ali Salajegheh · 2016 · Springer eBooks
  27. Macrocyclization of an all-D linear peptide improves target affinity and imparts cellular activity: A novel stapled α-helical peptide modality
    Srinivasaraghavan Kannan, Pietro G. A. Aronica, Simon Ng, Dawn Thean, Yuri Frosi, Sharon Min Qi Chee, Shimin Jiang, Tsz Ying Yuen, Ahmad Sadruddin, Hung Yi Kristal Kaan et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Geldanamycin Enhances the Radioprotective Effect of Peroxyredoxin 6 in Irradiated 3T3 Fibroblasts
    Elena G. Novoselova, Olga Valentinovna Glushkova, Mars G. Sharapov, Maxim O. Khrenov, Svetlana B. Parfenyuk, Sergey M. Lunin, T. V. Novoselova, A. K. Mubarakshina, Ruslan G. Goncharov, Eugeny E. Fesenko · 2022 · Doklady Biochemistry and Biophysics
  29. Post-translational regulation of the Numb/Notch pathway in neurogenesis and cancer by Dlk2
    Stéphanie B. Telerman, Russell S. Hamilton, Ben Shaw, Jordan D. Dimitrov, Benjamin Steventon, Anne C. Ferguson‐Smith · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Completed Clinical Trials of p53 Gene Therapy in Cancer: A ClinicalTrials.gov-Based Analysis
    Nasser M. Alorfi · 2025 · Research Square
  31. Mitochondrial localisation of hTERT protects against nuclear DNA damage and mitochondrial ROS production after endogenous and exogenous stress
    Chatchawan Singhapol · 2013
  32. Molecular Signature of the TP53 Pathway in Glioblastoma Genomics: Clinical Profiling and Integrated Analysis
    Amin Ejlali, Gholamreza Motalleb, naser sancholi · 2025 · International journal of basic science in medicine
  33. The role of adenoviral capsid protein VI in cell cycle modulation
    Remi Vaillant · 2014
  34. The role of NEDD8 pathway in cell invasion and strategies for the use of NEDD8 inhibitors in the clinic
    Lara J. Bou Malhab · 2016 · theses.fr (ABES)
  35. Genotype-Dependent Dysregulation of the MDM2–p53 Axis and Breast Cancer Susceptibility in Bangladeshi Women: A Cas-Control Study
    Mahim Hassan Chowdhury, Farzana Islam, Adiba Ayesha Khan, Md. Ayman Siddique, Nushaiba Binte Hasan, Mahinul Islam Samrat, Mehrin Haque Tanisha, Jarin Tasnim, Samiha Mahjabin, Md. Nazmul Islam et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  36. The Enigmatic Tumor Suppressor p53 Biomolecule: Its Role and Prognostic and Predictive Values in Cancer Therapy and Precision Medicine
    Zahid Hussain Siddik · 2026 · Biomolecules
  37. Towards anticancer drug design: Allosteric rewiring of the MDM2–MDMX RING interface by K478R and N448C perturbs structural and functional dynamics
    Adeniyi T. Adewumi, Lucas Sekele, Wande M. Oluyemi, Shadrach Chinecherem Eze, Salerwe Mosebi · 2026 · Research Square
  38. Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study
    Mahim Hassan Chowdhury, Farzana Islam, Adiba Ayesha Khan, Md. Ayman Siddique, Nushaiba Binte Hasan, Mahinul Islam Samrat, Mehrin Haque Tanisha, Jarin Tasnim, Samiha Mahjabin, Md. Nazmul Islam et al. · 2026 · PLoS ONE
  39. Cholesterol and p53 promote senescence and systemic fibrosis in metabolic dysfunction-associated steatohepatitis
    Celine I Wittke, Dale M. Watt, Liam Butler, Anabel Martinez Lyons, Cassie J. Clarke, Clara Mullen, Nicola Clements, Amy Lawlor, Dimitris Athineos, Ashleigh Young et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Completed clinical trials of p53-targeted therapeutic strategies in cancer
    Nasser M. Alorfi, Nouf M. Alourfi · 2026 · Medicine